中国药物经济学
中國藥物經濟學
중국약물경제학
CHINA JOURNAL OF PHARMACEUTICAL ECONOMICS
2015年
2期
97-98
,共2页
腹水超浓缩回输术%肝硬化顽固性腹水%治疗方法
腹水超濃縮迴輸術%肝硬化頑固性腹水%治療方法
복수초농축회수술%간경화완고성복수%치료방법
Super concentrated ascites reinfusion%Intractable ascites of cirrhosis%Treatment method
目的:探讨常规治疗联合腹水超滤浓缩回输术在治疗肝硬化顽固性腹水中的效果。方法选取2013年4月至2014年5月收治的肝硬化顽固性腹水患者38例,随机分成试验组与对照组,各19例,对照组患者进行常规治疗,试验组患者在其基础上联合腹水超滤浓缩回输术治疗,比较两组患者的疗效及并发症。结果试验组患者总有效率为94.7%,对照组患者总有效率为63.2%,两组疗效比较差异有统计学意义(P<0.05);两组患者并发症比较差异无统计学意义(P>0.05)。结论常规治疗联合腹水超滤浓缩回输术的治疗用于肝硬化顽固性腹水患者,可明显改善患者存在的电解质紊乱,有效缓解肝硬化顽固性腹水。
目的:探討常規治療聯閤腹水超濾濃縮迴輸術在治療肝硬化頑固性腹水中的效果。方法選取2013年4月至2014年5月收治的肝硬化頑固性腹水患者38例,隨機分成試驗組與對照組,各19例,對照組患者進行常規治療,試驗組患者在其基礎上聯閤腹水超濾濃縮迴輸術治療,比較兩組患者的療效及併髮癥。結果試驗組患者總有效率為94.7%,對照組患者總有效率為63.2%,兩組療效比較差異有統計學意義(P<0.05);兩組患者併髮癥比較差異無統計學意義(P>0.05)。結論常規治療聯閤腹水超濾濃縮迴輸術的治療用于肝硬化頑固性腹水患者,可明顯改善患者存在的電解質紊亂,有效緩解肝硬化頑固性腹水。
목적:탐토상규치료연합복수초려농축회수술재치료간경화완고성복수중적효과。방법선취2013년4월지2014년5월수치적간경화완고성복수환자38례,수궤분성시험조여대조조,각19례,대조조환자진행상규치료,시험조환자재기기출상연합복수초려농축회수술치료,비교량조환자적료효급병발증。결과시험조환자총유효솔위94.7%,대조조환자총유효솔위63.2%,량조료효비교차이유통계학의의(P<0.05);량조환자병발증비교차이무통계학의의(P>0.05)。결론상규치료연합복수초려농축회수술적치료용우간경화완고성복수환자,가명현개선환자존재적전해질문란,유효완해간경화완고성복수。
Objective To conventional treatment combined with ascites reinfusion method in the treatment of intractable ascites due to cirrhosis of the effect.Methods 38 patients from 2013 April to 2014 May were intractable ascites of cirrhosis,were randomly divided into experimental group and control group,each 19 cases,the control group patients received routine treatment,patients in experimental group on the basis of combined ultrafiltration and reinfusion of ascites treatment,compared two groups of patients with curative effect and complications.Results In experiment group,the total efficiency of 94.7%,patients in the control group the total effective rate was 63.2%,there was significant difference between two groups(P<0.05);the curative effect of two groups of complications were not significant(P>0.05).Conclusion Conventional therapy combined with ascites reinfusion method for patients with refractory ascites of cirrhosis of the liver,can obviously improve the electrolyte disorders in patients with existing,more effectively relieve intractable ascites of cirrhosis.